Our cancer test “N-NOSE” will be rolled out in 47 prefectures nationwide this summer.
We have established “N-NOSE” as an entrance test for cancer screening, which allows you to comprehensively check the risk of cancer just by staying at home. We are aiming to lead to early detection and treatment of cancer in people with cancer.
We as HIROTSU Bio Science Inc. (Head Office: Chiyoda-ku, Tokyo; Representative: Takaaki Hirotsu (Hereinafter referred to as “HIROTSU”) are pleas . . .
2024.04.01On March 18, 2024, an reveiw articles on cancer screening by a third-party research team (Romania) was published in "Cancers", an oncology journ . . .
2024.03.29HIROTSU Bioscience Inc. (Head Office: Chiyoda-ku, Tokyo, Representative: Takaaki Hirotsu, hereinafter referred to as “HIROTSU) has verified the . . .
2024.02.29